Reaching an evidence-based prognosis for personalized treatment of multiple sclerosis
Reaching an evidence-based prognosis for personalized treatment of multiple sclerosis
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Personalized treatment is ideal for multiple sclerosis (MS) owing to the heterogeneity of clinical features, but current knowledge gaps, including validation of biomarkers and treatment algorithms, limit practical implementation. The contemporary approach to personalized MS therapy depends on evidence-based prognostication, an initial treatment cho...
Alternative Titles
Full title
Reaching an evidence-based prognosis for personalized treatment of multiple sclerosis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2202672375
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2202672375
Other Identifiers
ISSN
1759-4758
E-ISSN
1759-4766
DOI
10.1038/s41582-019-0170-8
